Why AT&T Is Buying Time Warner, And Why So Many People Aren’t Happy About It

Why AT&T Is Buying Time Warner, And Why So Many People Aren’t Happy About It

The time from new rumor to signed deal was only about two days, and yet here we are: AT&T is putting the moves on Time Warner, planning to bring the content powerhouse under its roof. This proposal will now, of course, have to grind its way through the gears of government approval. But while this proposal is a giant deal for two giant companies, the name that’s likely to come up more than any other in all the comments back-and-forth is neither Time Warner nor AT&T, but rather a competitor: Comcast. [More]


Senator Wants To Know What’s Up With Samsung’s Lithium-Ion Batteries

While Samsung says it tested the batteries used in its now recalled and defunct Galaxy Note 7 devices before putting them in consumers’ hands, there are still plenty of unanswered questions related to how such a dangerous problem — exploding phones — could have gone unnoticed.  [More]


Mylan To Pay $465M To Settle EpiPen Medicaid Pricing Scandal; Critics Call Deal “Inadequate”

Amid recent revelations that EpiPen maker Mylan has been overcharging U.S. taxpayers for potentially hundreds of millions of dollars since at least 2011, the drug company says it has agreed to pay $465 million to close the book on a federal investigation into its Medicaid pricing — all without admitting any liability. [More]


Lawmakers: Takata Bankruptcy Could Leave Consumers On The Hook For Repairs

Facing billions of dollars in losses related to fines, penalties, repair costs, and other expenses connected to the massive recall of shrapnel-shooting airbags, Takata is reportedly looking at restructuring through bankruptcy as an option. But if the auto parts maker goes this route, would we all be stuck footing the bill to replace the defective safety devices?  [More]

ken fager

Senators Urge Continued Oversight Of For-Profit Colleges Amid Another Closure

For-profit college operators continued to take hits this week, as lawmakers called for federal aid restriction on the Computer Systems Institute brand, and smaller Regency Beauty Institute brand announced it would close.  [More]

Brad Clinesmith

Ahead Of Tomorrow’s Vote, Several Senators Urge FCC To Approve Set-Top Box Plan

Tomorrow, at its monthly open meeting, the FCC will be voting on the most controversial rule it’s undertaken this year: whether, and how, to let consumers get out of paying their cable company a fee every month for mandatory set-top boxes.


Senators Ask DOJ To Investigate Mylan Over Possible EpiPen Medicaid Fraud

Phillip Bradshaw

EpiPen maker Mylan might have thought that dealing with the public shaming of a congressional hearing would be the low point of its ongoing price-hike scandal, but lawmakers continue to scrutinize the drug company and are now calling for a federal investigation into the possibility that Mylan was deliberately mis-categorizing the emergency allergy medication in order to reap bigger payments from Medicaid. [More]


Yahoo Facing Lawsuits, Senate Inquiry, Possibly Merger Issues After Massive Data Breach

Last week was pretty rough for Yahoo, which confirmed on Thursday that it suffered a major data breach affecting more than half a billion (yes, with a B) users. Now 500 million people with Yahoo accounts are trying to figure out what to do next… but they’re not the only ones. [More]


Advocates, Lawmakers, Even Best Buy Call On FCC To Approve Cable Box Plan

The Federal Communications Commission has been stewing over a proposal that would shake up the cable set-top box market for months. They’ve got a vote on the final proposal coming up this week, but in the face of partisan bickering and opposition from the cable industry, the matter has become controversial. So today, a whole passel of folks called on the FCC to approve the measure ASAP, for consumers’ sake.



Travelers Just Want To Know What A Flight Will Cost Upfront

There are all kinds of annoyances involved in flying, whether it’s that jerk in front of you who slammed his seat back into your knees or the fees you pay to check a bag and select your seat. But one of the most infuriating things for passengers these days? Not knowing how much your airfare will cost by the time all is said and done.



FCC Explains Cable Set-Top Box Proposal, Everything Else It Does To Senate (Again)

Election years beget a compressed Congressional schedule. The House and Senate just got back to work in D.C. after a six-week break, and will be taking another six-week break as soon as we hit October 1 (picking up again after the election), so everything the committees want to do has to get done now. Like bringing in all five FCC commissioners for another episode of everyone’s favorite series, The FCC Explains And Defends Literally Everything It’s Doing. [More]


New York Launches Antitrust Investigation Into EpiPen Schools Program

Amid calls for drugmaker Mylan to drop the price of emergency allergy treatment EpiPen, the attorney general for the state of New York has launched an antitrust investigation into a program that helps to put EpiPens in schools, potentially to the detriment of competition. At the same time, U.S. lawmakers are pushing regulators for a federal antitrust probe on the program. [More]

Explosion On Truck Carrying Takata Airbags Not Caused By Improper Shipping

Explosion On Truck Carrying Takata Airbags Not Caused By Improper Shipping

On Aug. 22, a truck carrying potentially volatile airbags made by auto parts company Takata exploded, killing one person and injuring four others. Today, federal safety regulators said that the tragic incident could not be blamed on improper shipping. [More]


Senator: EpiPen Generic Announcement “Raises As Many Questions As Solutions”

This morning, drug company Mylan announced that it will soon introduce a lower-cost (but still not cheap) generic version of its popular EpiPen emergency allergy treatment. In response, one senator who has been critical of Mylan’s actions says more must be done to make the life-saving drug available. [More]


6 Things You Should Know About Heather Bresch, The CEO Behind EpiPen Price Hike

As you may have heard, the cost of a life-saving EpiPen from drug maker Mylan increased as much as 600% in just nine years, causing lawmakers and health advocates to call on the drug company — and its CEO Heather Bresch — to lower the cost and provide answers for its increase in the first place. But that could be difficult given the executive’s personal connections not only to the medication, but one legislator.  [More]


Senators Demand Mylan Lower Cost Of Life-Saving Epipens, Call For Congressional Hearing

The cost of a life-saving EpiPen from drug maker Mylan increased as much as 600% in just nine years. That’s simply too much, lawmakers say, with some legislators now calling on the pharmaceutical giant to drop its price immediately, while others are pushing for a congressional hearing on the matter.  [More]